Hostname: page-component-5cf477f64f-rdph2 Total loading time: 0 Render date: 2025-04-02T05:29:49.776Z Has data issue: false hasContentIssue false
  • English
  • Français

Paliperidone for a patient with delayed-onset performance and memory dysfunction and neuropsychiatric symptoms associated with carbon monoxide intoxication

Published online by Cambridge University Press:  24 June 2014

Seong-Beom Oh ,
Myung-Ho Lim ,
Ho-Jang Kwon ,
Dong-Soo Yoo  and
Chang-Min Lee
Seong-Beom Oh
Affiliation:
Department of Emergency Medicine, College of Medicine, Cheonan, South Korea
Myung-Ho Lim*
Affiliation:
Department of Psychiatry, Environmental Health Center, College of Medicine, Cheonan, South Korea
Ho-Jang Kwon
Affiliation:
Department of Preventive Medicine, Environmental Health Center, College of Medicine, Cheonan, South Korea
Dong-Soo Yoo
Affiliation:
Department of Radiology, College of Medicine, Cheonan, South Korea
Chang-Min Lee
Affiliation:
Department of Neurology, College of Medicine, Cheonan, South Korea
*
Myung-Ho Lim, MD Department of Psychiatry, Environmental Center, College of Medicine, Dankook University, Manghyang Rho 359, Cheonan 330714, South Korea. Tel: +82 10 26401498; Fax: +82 42 5613007; E-mail: paperose@dku.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comment & Critique
Information
Acta Neuropsychiatrica , Volume 23 , Issue 4 , August 2011 , pp. 194 - 195
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Ernst, A, Zibrak, JD.Carbon monoxide poisoning. N Engl J Med 1998;339:1603–1608.CrossRefGoogle ScholarPubMed
2.Weaver, LK.Clinical practice: carbon monoxide poisoning. N Engl J Med 2009;360:1217–1225.CrossRefGoogle ScholarPubMed
3.Choi, IS.Carbon monoxide poisoning: systemic manifestations and complications. J Korean Med Sci 2001;16:253–261.CrossRefGoogle ScholarPubMed
4.Hu, MC, Shiah, IS, Yeh, CB, Chen, HK, Chen, CK.Ziprasidone in the treatment of delayed carbon monoxide. Encephalopathy 2006;30:755–757.Google ScholarPubMed
5.Pae, CU, Kim, TS, Lee, C, Paik, IH.Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication. J Neuropsychiat Clin Neurosci 2006;18:130–131.CrossRefGoogle ScholarPubMed
6.Leysen, JE, Janssen, PM, Megens, AA, Schotte, A.Risperidone: a novel antipsychotic with balanced serotonin–dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiat 1994;55(Suppl): 5–12.Google Scholar
7.Richelson, E, Souder, T.Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 2000;68:29–39.CrossRefGoogle ScholarPubMed
8.Nasrallah, HA.Atypical antipsychotic-induced metabolic side effects: insights from receptor binding profiles. Mol Psychiat 2008;13:27–35.Google Scholar
9.Fowler, JA, Bettinger, TL, Argo, TR.Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia. Clin Ther 2008;30:231–248.Google Scholar
10.Yulug, B, Yildiz, A, Guzel, O, Kilic, E, Schabitz, WR, Kilic, E.Risperidone attenuates brain damage after focal cerebral ischemia in vivo. Brain Res Bull 2006;69:656–659.Google Scholar
11.Correll, CU, Leucht, S, Kane, JM.Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of l-year studies. Am J Psychiat 2004;161:414–425.Google Scholar
12.Tandon, R, Jibson, MD.Extrapyramidal side effects of antipsychotic treatment: scope of problem and impact on outcome. Ann Clin Psychiat 2002;14:123–129.CrossRefGoogle ScholarPubMed
13.Woodward, ND, Purdon, SE, Meltzer, HY, Zald, DH.A metaanalysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Schizophr Res 2007;89:211–224.Google Scholar
14.Keefe, RS, Bilder, RM, Davis, SM et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiat 2007;64:633–647.CrossRefGoogle ScholarPubMed
15.Grootens, KP, Van Veelen, NM, Peuskens, J et al. Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. Schizophr Bull 2011;37:352–361.CrossRefGoogle ScholarPubMed
16.Van Veelen, NM, Grootens, KP, Peuskens, J et al. Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. Schizophr Res 2010;120:191–198.Google Scholar
17.Nussbaum, A, Stroup, TS.Paliperidone for schizophrenia. Cochrane Database Syst Rev 2008;16:CD006369.Google Scholar